chr11-46875946-C-G
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_002334.4(LRP4):c.3557G>C(p.Trp1186Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W1186F) has been classified as Uncertain significance.
Frequency
Consequence
NM_002334.4 missense
Scores
Clinical Significance
Conservation
Publications
- Cenani-Lenz syndactyly syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- congenital myasthenic syndrome 17Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sclerosteosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sclerosteosis 2Inheritance: SD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LRP4 | NM_002334.4 | c.3557G>C | p.Trp1186Ser | missense_variant | Exon 26 of 38 | ENST00000378623.6 | NP_002325.2 | |
| LRP4 | XM_017017734.2 | c.3557G>C | p.Trp1186Ser | missense_variant | Exon 26 of 39 | XP_016873223.1 | ||
| LRP4 | XM_011520103.3 | c.2753G>C | p.Trp918Ser | missense_variant | Exon 20 of 32 | XP_011518405.1 | ||
| LRP4 | XM_011520104.3 | c.1322G>C | p.Trp441Ser | missense_variant | Exon 11 of 23 | XP_011518406.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251420 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461888Hom.: 0 Cov.: 34 AF XY: 0.00000550 AC XY: 4AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74346 show subpopulations
ClinVar
Submissions by phenotype
Sclerosteosis 2 Pathogenic:1
- -
not provided Pathogenic:1
Reported as a heterozygous, de novo variant in a patient with sclerosteosis (PMID: 21471202); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26751728, 24234652, 21471202, 35052419) -
Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Uncertain:1
This sequence change replaces tryptophan with serine at codon 1186 of the LRP4 protein (p.Trp1186Ser). The tryptophan residue is highly conserved and there is a large physicochemical difference between tryptophan and serine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be de novo in an individual affected with sclerosteosis (PMID: 21471202). ClinVar contains an entry for this variant (Variation ID: 30410). Experimental studies have shown that this missense change impairs LRP4 protein function in vitro (PMID: 21471202, 24234652). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at